MPP wins with the SourSweet project

The business unit is working on a new active ingredient.

The research project is still in its infancy. Initial molecule developments and trials are taking place at the MPP research laboratory in Wilmington, USA. However, for patent reasons, no further details about the project can or may be disclosed. Xpress will report in detail at a later date. Suffice it to say that the project also has a cross-BU aspect. The scaling up from laboratory scale to initial pilot production is to be carried out jointly with the Saltigo business unit in Leverkusen. In line with the ONE LANXESS philosophy, development for large-scale production is also to be carried out jointly with Saltigo.

“Precisely because we are still in the early stages of development, we are very pleased to have secured the LIFE budget. This will enable us to strengthen our research laboratory in Wilmington, build new research capabilities, and advance the project more quickly,” says project manager Mark Kubik, MPP business unit, adding: “The additional resources will allow us to conduct further development experiments, which will increase the chances of a successful market entry.”